D. Powell

Oncology · Nature Reviews. Cancer · 2006–2019

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom D. Powell trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. S. Rosenberg

Papers from D. Powell's perspective

Ordered by how strongly the researchers D. Powell trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses (Cancer Research)
  2. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival (Nature Medicine)
  3. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. (Science)
  4. Regulation of immune responses by L-arginine metabolism (Nature reviews. Immunology)
  5. Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. (Journal of Clinical Investigation)
  6. Safety and clinical activity of combined PD-1 (nivolumab) and CTLA-4 (ipilimumab) blockade in advanced melanoma patients (New England Journal of Medicine)
  7. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. (Proceedings of the National Academy of Sciences of the United States of America)
  8. Human T cell responses against melanoma. (Annual Review of Immunology)
  9. Toward an understanding of NKT cell biology: progress and paradoxes. (Annual Review of Immunology)
  10. Interleukin 2 Signaling Is Required for CD4+ Regulatory T Cell Function (Journal of Experimental Medicine)

Their papers